WebMay 25, 2024 · Bavarian shares traded up 16% at 1019 GMT and have risen more than 40% since the company announced a similar vaccine supply deal with an undisclosed country on May 19. The stock is down 28% this year. WebJul 26, 2024 · Bavarian Nordic (BAVA.Copenhagen), the Danish firm that makes the vaccine known as Jynneos in the U.S., had a market value of 9.4 billion Danish Krone, or $1.2 billion, in early May, when U.K ...
Bavarian Nordic (BVNRY) Stock Jumps 70% on Monkeypox …
WebView today's Bavarian Nordic stock price and latest BAVA news and analysis. Create real-time notifications to follow any changes in the live stock price. ... Shares in Danish-German biotech ... WebApr 18, 2024 · Bavarian Nordic's vaccine candidates are currently produced on chicken embryonic fibroblast (CEF) and the company will explore the potential of switching to Valneva's EB66 ® technology. eastern time daylight saving
Bavarian Nordic A/S Launches Offering of up to 7,046,839 New …
WebMar 3, 2024 · We have found 6 companies that stand out by either having several smaller stock price triggers or at least having one game-changing event that can seriously transform the company. The selected companies are: Ascelia Pharma, Bavarian Nordic, Curasight, Evaxion Biotech, Fluoguide and Scandion Oncology. Coming stock price … WebApr 10, 2024 · Bavarian Nordic A/S - BVNRY Stock Forecast, Price & News $9.48 -0.06 (-0.63%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $9.48 $9.52 50-Day … WebApr 6, 2024 · Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two area s: Cancer Immunotherapy and Infectious Disease. eastern time and pacific time